Amir Belson, MD

Amir Belson, MD has had an extensive work experience in various companies and positions. Amir is the Founder and Board of Directors (BOD) Member of Radiaction Ltd. since April 2008. In 2023, they became a BOD Member of LEM Surgical AG. Amir is the Founder and BOD Chairman of Follisave, Venocare, Inc., and Ceretrieve since September 2021, and September 2020, respectively. Amir is also a BOD Member of IOP MEDICAL since 2021. In 2020, they served as a BOD Member in Planterra Foods and a BOD Member of Rambach MedTech since 2019. Amir also has experience as a BOD Member in Relimetrics, Inc. since August 2017. Furthermore, they are the Founder and BOD Chairman of Emboline, Inc. since October 2011.

Amir Belson, MD has a distinguished education history in the field of medicine. Amir completed a Biodesign Fellowship at Stanford University, where they focused on interdisciplinary approaches to medical innovation. Prior to this, they obtained a Diploma and Master's Degree in Pediatrics from the Sackler School of Medicine at Tel Aviv University. Belson's strong academic foundation in medicine began with their MD degree from the Technion - Israel Institute of Technology's School of Medicine. Through these educational experiences, Belson has developed a deep understanding of medical advancements and is equipped with the skills necessary to contribute to the medical field.